Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Vale, WW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bilezikjian, LM; Blount, AL; Corrigan, AZ; Leal, A; Chen, Y; Vale, WW
      Actions of activins, inhibins and follistatins: Implications in anterior pituitary function

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    2. Reyes, TM; Lewis, K; Perrin, MH; Kunitake, KS; Vaughan, J; Arias, CA; Hogenesch, JB; Gulyas, J; Rivier, J; Vale, WW; Sawchenko, PE
      Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    3. Lewis, K; Li, C; Perrin, MH; Blount, A; Kunitake, K; Donaldson, C; Vaughan, J; Reyes, TM; Gulyas, J; Fischer, W; Bilezikjian, L; Rivier, J; Sawchenko, PE; Vale, WW
      Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    4. Perrin, MH; Fischer, WH; Kunitake, KS; Craig, AG; Koerber, SC; Cervini, LA; Rivier, JE; Groppe, JC; Greenwald, J; Nielsen, SM; Vale, WW
      Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factorreceptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    5. Bilezikjian, LM; Corrigan, AZ; Blount, AL; Chen, Y; Vale, WW
      Regulation and actions of Smad7 in the modulation of activin, inhibin, andtransforming growth factor-beta signaling in anterior pituitary cells

      ENDOCRINOLOGY
    6. Sutton, SW; Akhtar, M; Schmidt, K; Fischer, WH; Vale, WW; Craig, AG
      Characterization of the N-linked glycan of recombinantly-expressed corticotropin releasing factor binding protein

      EUROPEAN JOURNAL OF MASS SPECTROMETRY
    7. Bale, TL; Contarino, AB; Smith, GW; Chan, R; Gold, LH; Sawchenko, PE; Koob, GF; Vale, WW; Lee, KF
      Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress

      NATURE GENETICS
    8. Chan, RKW; Vale, WW; Sawchenko, PE
      Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain

      NEUROSCIENCE
    9. Nielsen, SM; Nielsen, LZ; Hjorth, SA; Perrin, MH; Vale, WW
      Constitutive activation of tethered-peptide/corticotropin-releasing factorreceptor chimeras

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    10. Bradbury, MJ; McBurnie, MI; Denton, DA; Lee, KF; Vale, WW
      Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice

      ENDOCRINOLOGY
    11. Kageyama, K; Gaudriault, GE; Bradbury, MJ; Vale, WW
      Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines

      ENDOCRINOLOGY
    12. Contarino, A; Dellu, F; Koob, GF; Smith, GW; Lee, KF; Vale, WW; Gold, LH
      Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice

      ENDOCRINOLOGY
    13. Greenwald, J; Fischer, WH; Vale, WW; Choe, S
      Three-finger toxin fold for the extracellular ligand-binding domain of thetype II activin receptor serine kinase.

      NATURE STRUCTURAL BIOLOGY
    14. Aubry, JM; Pozzoli, G; Vale, WW
      Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala

      NEUROSCIENCE LETTERS
    15. Cepoi, D; Sutton, S; Arias, C; Sawchenko, P; Vale, WW
      Ovine genomic urocortin: cloning, pharmacologic characterization, and distribution of central mRNA

      MOLECULAR BRAIN RESEARCH
    16. Perrin, MH; Sutton, SW; Cervini, LA; Rivier, JE; Vale, WW
      Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    17. Rivier, JE; Kirby, DA; Lahrichi, SL; Corrigan, A; Vale, WW; Rivier, CL
      Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat

      JOURNAL OF MEDICINAL CHEMISTRY
    18. Bittencourt, JC; Vaughan, J; Arias, C; Rissman, RA; Vale, WW; Sawchenko, PE
      Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors

      JOURNAL OF COMPARATIVE NEUROLOGY
    19. Peto, CA; Arias, C; Vale, WW; Sawchenko, PE
      Ultrastructural localization of the corticotropin-releasing factor-bindingprotein in rat brain and pituitary

      JOURNAL OF COMPARATIVE NEUROLOGY
    20. Takabe, K; Lebrun, JJ; Nagashima, Y; Ichikawa, Y; Mitsuhashi, M; Momiyama, N; Ishikawa, T; Shimada, H; Vale, WW
      Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation

      ENDOCRINOLOGY
    21. Donaldson, CJ; Vaughan, JM; Corrigan, AZ; Fischer, WH; Vale, WW
      Activin and inhibin binding to the soluble extracellular domain of activinreceptor II

      ENDOCRINOLOGY
    22. Turnbull, AV; Smith, GW; Lee, S; Vale, WW; Lee, KF; Rivier, C
      CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation

      ENDOCRINOLOGY
    23. Kageyama, K; Bradbury, MJ; Zhao, LY; Blount, AL; Vale, WW
      Urocortin messenger ribonucleic acid: Tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids

      ENDOCRINOLOGY
    24. Turnbull, AV; Vaughan, J; Rivier, JE; Vale, WW; Rivier, C
      Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat

      ENDOCRINOLOGY
    25. LOVEJOY DA; AUBRY JM; TURNBULL A; SUTTON S; POTTER E; YEHLING J; RIVIER C; VALE WW
      ECTOPIC EXPRESSION OF THE CRF-BINDING PROTEIN - MINOR IMPACT ON HPA AXIS REGULATION BUT INDUCTION OF SEXUALLY DIMORPHIC WEIGHT-GAIN

      Journal of neuroendocrinology
    26. ZHAO LY; DONALDSON CJ; SMITH GW; VALE WW
      THE STRUCTURES OF THE MOUSE AND HUMAN UROCORTIN GENES (UCN AND UCN)

      Genomics
    27. Lovejoy, DA; Hewett-Emmett, D; Porter, CA; Cepoi, D; Sheffield, A; Vale, WW; Tashian, RE
      Evolutionarily conserved, "acatalytic" carbonic anhydrase-related protein XI contains a sequence motif present in the neuropeptide sauvagine: The human CA-RP XI gene (CA11) is embedded between the secretor gene cluster and the DBP gene at 19q13.3

      GENOMICS
    28. LODDICK SA; LIU XJ; LU ZX; LIU CL; BEHAN DP; CHALMERS DC; FOSTER AC; VALE WW; LING N; DESOUZA EB
      DISPLACEMENT OF INSULIN-LIKE GROWTH-FACTORS FROM THEIR BINDING-PROTEINS AS A POTENTIAL TREATMENT FOR STROKE

      Proceedings of the National Academy of Sciences of the United Statesof America
    29. CERVINI LA; DONALDSON CJ; KOERBER SC; VALE WW; RIVIER JE
      HUMAN GROWTH HORMONE-RELEASING HORMONE HGHRH(1-29)-NH2 - SYSTEMATIC STRUCTURE-ACTIVITY RELATIONSHIP STUDIES

      Journal of medicinal chemistry
    30. BILEZIKJIAN LM; TURNBULL AV; CORRIGAN AZ; BLOUNT AL; RIVIER CL; VALE WW
      INTERLEUKIN-1-BETA REGULATES PITUITARY FOLLISTATIN AND INHIBIN ACTIVIN BETA(B) MESSENGER-RNA LEVELS AND ATTENUATES FSH-SECRETION IN RESPONSE TO ACTIVIN-A/

      Endocrinology
    31. PERRIN MH; SUTTON S; BAIN DL; BERGGREN WT; VALE WW
      THE FIRST EXTRACELLULAR DOMAIN OF CORTICOTROPIN-RELEASING FACTOR-R1 CONTAINS MAJOR BINDING DETERMINANTS FOR UROCORTIN AND ASTRESSIN

      Endocrinology
    32. HOLMBERG BJ; MORRISON CD; DANIEL JA; BOLDEN OU; GAZAL OS; VALE WW; KEISLER DH
      RESPONSE OF THE REPRODUCTION - NUTRITION AXIS IN OVARIECTOMIZED EWES TO INTRACEREBROVENTRICULAR INFUSION OF UROCORTIN

      Biology of reproduction
    33. GADDYKURTEN D; COKER JK; VAUGHAN JM; VALE WW; JILKA RL; MANOLAGAS SC
      ATTENUATION OF OSTEOBLASTOGENESIS IN THE MURINE BONE-MARROW BY INHIBIN AND FOLLISTATIN - EVIDENCE FOR DISTINCT EFFECTS AT DIFFERENT STAGES OF THE PROCESS

      Journal of bone and mineral research
    34. HEINRICHS SC; MIN H; TAMRAZ S; CARMOUCHE M; BOEHME SA; VALE WW
      ANTISEXUAL AND ANXIOGENIC BEHAVIORAL CONSEQUENCES OF CORTICOTROPIN-RELEASING FACTOR OVEREXPRESSION ARE CENTRALLY MEDIATED

      Psychoneuroendocrinology
    35. LEBRUN JJ; VALE WW
      ACTIVIN AND INHIBIN HAVE ANTAGONISTIC EFFECTS ON LIGAND-DEPENDENT HETEROMERIZATION OF THE TYPE-I AND TYPE-II ACTIVIN RECEPTORS AND HUMAN ERYTHROID-DIFFERENTIATION

      Molecular and cellular biology
    36. TSUCHIDA K; SAWCHENKO PE; NISHIKAWA SI; VALE WW
      MOLECULAR-CLONING OF A NOVEL TYPE-I RECEPTOR SERINE THREONINE KINASE FOR THE TGF-BETA SUPERFAMILY FROM RAT-BRAIN/

      Molecular and cellular neurosciences
    37. HEINRICHS SC; STENZELPOORE MP; GOLD LH; BATTENBERG E; BLOOM FE; KOOB GF; VALE WW; PICH EM
      LEARNING IMPAIRMENT IN TRANSGENIC MICE WITH CENTRAL OVEREXPRESSION OFCORTICOTROPIN-RELEASING FACTOR

      Neuroscience
    38. HEINRICHS SC; LAPSANSKY J; BEHAN DP; CHAN RKW; SAWCHENKO PE; LORANG M; LING N; VALE WW; DESOUZA EB
      CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN LIGAND INHIBITOR BLUNTS EXCESSIVE WEIGHT-GAIN IN GENETICALLY-OBESE ZUCKER RATS AND RATS DURING NICOTINE WITHDRAWAL

      Proceedings of the National Academy of Sciences of the United Statesof America
    39. GRIGORIADIS DE; LIU XJ; VAUGHN J; PALMER SF; TRUE CD; VALE WW; LING N; DESOUZA EB
      I-125 TYR(0)-SAUVAGINE - A NOVEL HIGH-AFFINITY RADIOLIGAND FOR THE PHARMACOLOGICAL AND BIOCHEMICAL-STUDY OF HUMAN CORTICOTROPIN-RELEASING FACTOR(2-ALPHA) RECEPTORS

      Molecular pharmacology
    40. DONALDSON CJ; SUTTON SW; PERRIN MH; CORRIGAN AZ; LEWIS KA; RIVIER JE; VAUGHAN JM; VALE WW
      CLONING AND CHARACTERIZATION OF HUMAN UROCORTIN (VOL 137, PG 2167, 1996)

      Endocrinology
    41. DONALDSON CJ; SUTTON SW; PERRIN MH; CORRIGAN AZ; LEWIS KA; RIVIER JE; VAUGHAN JM; VALE WW
      CLONING AND CHARACTERIZATION OF HUMAN UROCORTIN

      Endocrinology
    42. POZZOLI G; BILEZIKJIAN LM; PERRIN MH; BLOUNT AL; VALE WW
      CORTICOTROPIN-RELEASING FACTOR (CRF) AND GLUCOCORTICOIDS MODULATE THEEXPRESSION OF TYPE-1 CRF RECEPTOR MESSENGER-RIBONUCLEIC-ACID IN RAT ANTERIOR-PITUITARY CELL-CULTURES

      Endocrinology
    43. BEHAN DP; CEPOI D; FISCHER WH; PARK M; SUTTON S; LOWRY PJ; VALE WW
      CHARACTERIZATION OF A SHEEP BRAIN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN (VOL 709, PG 265, 1996)

      Brain research
    44. BEHAN DP; CEPOI D; FISCHER WH; PARK M; SUTTON S; LOWRY PJ; VALE WW
      CHARACTERIZATION OF A SHEEP BRAIN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN

      Brain research
    45. LOVEJOY DA; CORRIGAN AZ; NAHORNIAK CS; PERRIN MH; PORTER J; KAISER R; MILLER C; PANTOJA D; CRAIG AG; PETER RE; VALE WW; RIVIER JE; SHERWOOD NM
      STRUCTURAL MODIFICATIONS OF NONMAMMALIAN GONADOTROPIN-RELEASING-HORMONE (GNRH) ISOFORMS - DESIGN OF NOVEL GNRH ANALOGS

      Regulatory peptides
    46. BEHAN DP; DESOUZA EB; LOWRY PJ; POTTER E; SAWCHENKO P; VALE WW
      CORTICOTROPIN-RELEASING FACTOR (CRF) BINDING-PROTEIN - A NOVEL REGULATOR OF CRF AND RELATED PEPTIDES

      Frontiers in neuroendocrinology
    47. GADDYKURTEN D; VALE WW
      ACTIVIN INCREASES PHOSPHORYLATION AND DECREASES STABILITY OF THE TRANSCRIPTION FACTOR PIT-1 IN MTTW15 SOMATOTROPE CELLS

      The Journal of biological chemistry
    48. SUTTON SW; BEHAN DP; LAHRICHI SL; KAISER R; CORRIGAN A; LOWRY P; POTTER E; PERRIN MH; RIVIER J; VALE WW
      LIGAND REQUIREMENTS OF THE HUMAN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN

      Endocrinology
    49. TSUCHIDA K; VAUGHAN JM; WIATER E; GADDYKURTEN D; VALE WW
      INACTIVATION OF ACTIVIN-DEPENDENT TRANSCRIPTION BY KINASE-DEFICIENT ACTIVIN RECEPTORS

      Endocrinology
    50. STERN CD; YU RT; KAKIZUKA A; KINTNER CR; MATHEWS LS; VALE WW; EVANS RM; UMESONO K
      ACTIVIN AND ITS RECEPTORS DURING GASTRULATION AND THE LATER PHASES OFMESODERM DEVELOPMENT IN THE CHICK-EMBRYO

      Developmental biology
    51. BEHAN DP; POTTER E; LEWIS KA; JENKINS NA; COPELAND N; LOWRY PJ; VALE WW
      CLONING AND STRUCTURE OF THE HUMAN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN GENE (CRHBP) (VOL 16, PG 63, 1993)

      Genomics
    52. STENZELPOORE MP; HEINRICHS SC; RIVEST S; KOOB GF; VALE WW
      OVERPRODUCTION OF CORTICOTROPIN-RELEASING FACTOR IN TRANSGENIC MICE -A GENETIC MODEL OF ANXIOGENIC BEHAVIOR

      The Journal of neuroscience
    53. SALAMEH W; BHASIN S; STEINER BS; MCADAMS LA; PETERSON M; RIVIER JE; VALE WW; SWERDLOFF RS
      COMPARATIVE EFFECTS OF 2 DIFFERENT DELIVERY SYSTEMS ON GONADOTROPIN-RELEASING-HORMONE (GNRH) ANTAGONIST-INDUCED SUPPRESSION OF GONADOTROPINS AND TESTOSTERONE IN MAN

      Journal of andrology
    54. HUSKENHINDI P; TSUCHIDA K; PARK M; CORRIGAN AZ; VAUGHAN JM; VALE WW; FISCHER WH
      MONOMERIC ACTIVIN-A RETAINS HIGH RECEPTOR-BINDING AFFINITY BUT EXHIBITS LOW BIOLOGICAL-ACTIVITY

      The Journal of biological chemistry
    55. CAMERON VA; NISHIMURA E; MATHEWS LS; LEWIS KA; SAWCHENKO PE; VALE WW
      HYBRIDIZATION HISTOCHEMICAL-LOCALIZATION OF ACTIVIN RECEPTOR SUBTYPESIN RAT-BRAIN, PITUITARY, OVARY, AND TESTIS

      Endocrinology
    56. STENZEL P; ANGERER LM; SMITH BJ; ANGERER RC; VALE WW
      THE UNIVIN GENE ENCODES A MEMBER OF THE TRANSFORMING GROWTH-FACTOR-BETA SUPERFAMILY WITH RESTRICTED EXPRESSION IN THE SEA-URCHIN EMBRYO

      Developmental biology
    57. KASCKOW JW; PARKES DG; OWENS MJ; STIPETIC MD; HAN JH; NEMEROFF CB; VALE WW
      THE BE (2)-M17 NEUROBLASTOMA CELL-LINE SYNTHESIZES AND SECRETES CORTICOTROPIN-RELEASING FACTOR

      Brain research
    58. MATHEWS LS; VALE WW
      MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF ACTIVIN RECEPTORS

      Receptor
    59. PARKES DG; YAMAMOTO GY; VAUGHAN JM; VALE WW
      CHARACTERIZATION AND REGULATION OF CORTICOTROPIN-RELEASING FACTOR IN THE HUMAN HEPATOMA NPLC-KC CELL-LINE

      Neuroendocrinology
    60. FEIFEL D; VACCARINO FJ; RIVIER J; VALE WW
      EVIDENCE FOR A COMMON NEURAL MECHANISM MEDIATING GROWTH HORMONE-RELEASING FACTOR-INDUCED AND SOMATOSTATIN-INDUCED FEEDING

      Neuroendocrinology
    61. TSUCHIDA K; MATHEWS LS; VALE WW
      CLONING AND CHARACTERIZATION OF A TRANSMEMBRANE SERINE KINASE THAT ACTS AS AN ACTIVIN TYPE-I RECEPTOR

      Proceedings of the National Academy of Sciences of the United Statesof America
    62. CHEN RP; LEWIS KA; PERRIN MH; VALE WW
      EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR

      Proceedings of the National Academy of Sciences of the United Statesof America
    63. MCGRATH GA; GONCALVES RJ; UDUPA JK; GROSSMAN RI; PAVLOU SN; MOLITCH ME; RIVIER J; VALE WW; SNYDER PJ
      NEW TECHNIQUE FOR QUANTITATION OF PITUITARY-ADENOMA SIZE - USE IN EVALUATING TREATMENT OF GONADOTROPH ADENOMAS WITH A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST

      The Journal of clinical endocrinology and metabolism
    64. LINTON EA; PERKINS AV; WOODS RJ; EBEN F; WOLFE CDA; BEHAN DP; POTTER E; VALE WW; LOWRY PJ
      CORTICOTROPIN-RELEASING HORMONE-BINDING PROTEIN (CRH-BP) - PLASMA-LEVELS DECREASE DURING THE 3RD TRIMESTER OF NORMAL HUMAN-PREGNANCY

      The Journal of clinical endocrinology and metabolism
    65. MATHEWS LS; VALE WW
      CHARACTERIZATION OF TYPE-II ACTIVIN RECEPTORS - BINDING, PROCESSING, AND PHOSPHORYLATION

      The Journal of biological chemistry
    66. BILEZIKJIAN LM; VAUGHAN JM; VALE WW
      CHARACTERIZATION AND THE REGULATION OF INHIBIN ACTIVIN SUBUNIT PROTEINS OF CULTURED RAT ANTERIOR-PITUITARY-CELLS

      Endocrinology
    67. PENG C; HUANG THJ; JEUNG EB; DONALDSON CJ; VALE WW; LEUNG PCK
      EXPRESSION OF THE TYPE-II ACTIVIN RECEPTOR GENE IN THE HUMAN PLACENTA

      Endocrinology
    68. PERRIN MH; DONALDSON CJ; CHEN R; LEWIS KA; VALE WW
      CLONING AND FUNCTIONAL EXPRESSION OF A RAT-BRAIN CORTICOTROPIN-RELEASING FACTOR (CRF) RECEPTOR

      Endocrinology
    69. VAUGHAN JM; VALE WW
      ALPHA-2-MACROGLOBULIN IS A BINDING-PROTEIN OF INHIBIN AND ACTIVIN

      Endocrinology
    70. SANFORD LM; VOGLMAYR JK; VALE WW; ROBAIRE B
      PHOTOPEROID-MEDIATED INCREASES IN SERUM CONCENTRATIONS OF INHIBIN, FOLLICLE-STIMULATING-HORMONE, AND LUTEINIZING-HORMONE ARE ACCENTUATED INADULT SHORTENED-SCROTUM RAMS WITHOUT CORRESPONDING DECREASES IN TESTOSTERONE AND ESTRADIOL

      Biology of reproduction


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 23:02:46